Literature DB >> 28679531

Transcriptional regulation of the Nkx3.1 gene in prostate luminal stem cell specification and cancer initiation via its 3' genomic region.

Qing Xie1, Zhu A Wang2.   

Abstract

NK3 homeobox 1 (Nkx3.1), a transcription factor expressed in the prostate epithelium, is crucial for maintaining prostate cell fate and suppressing tumor initiation. Nkx3.1 is ubiquitously expressed in luminal cells of hormonally intact prostate but, upon androgen deprivation, exclusively labels a type of luminal stem cells named castration-resistant Nkx3.1-expressing cells (CARNs). During prostate cancer initiation, Nkx3.1 expression is frequently lost in both humans and mouse models. Therefore, investigating how Nkx3.1 expression is regulated in vivo is important for understanding the mechanisms of prostate stem cell specification and cancer initiation. Here, using a transgenic mouse line with destabilized GFP, we identified an 11-kb genomic region 3' of the Nkx3.1 transcription start site to be responsible for alterations in Nkx3.1 expression patterns under various physiological conditions. We found that androgen cell-autonomously activates Nkx3.1 expression through androgen receptor (AR) binding to the 11-kb region in both normal luminal cells and CARNs and discovered new androgen response elements in the Nkx3.1 3' UTR. In contrast, we found that, in Pten-/- prostate tumors, loss of Nkx3.1 expression is mediated at the transcriptional level through the 11-kb region despite functional AR in the nucleus. Importantly, the GFP reporter specifically labeled CARNs in the regressed prostate only in the presence of cell-autonomous AR, supporting a facultative model for CARN specification.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Nkx3.1; androgen; phosphatase and tensin homolog (PTEN); prostate cancer; stem cells; transcription

Mesh:

Substances:

Year:  2017        PMID: 28679531      PMCID: PMC5566512          DOI: 10.1074/jbc.M117.788315

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  NKX3.1 activates cellular response to DNA damage.

Authors:  Cai Bowen; Edward P Gelmann
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

3.  Prostate-specific and androgen-dependent expression of a novel homeobox gene.

Authors:  C J Bieberich; K Fujita; W W He; G Jay
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

4.  Tissue-specific expression of murine Nkx3.1 in the male urogenital system.

Authors:  P J Sciavolino; E W Abrams; L Yang; L P Austenberg; M M Shen; C Abate-Shen
Journal:  Dev Dyn       Date:  1997-05       Impact factor: 3.780

5.  Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

Authors:  David J Mulholland; Linh M Tran; Yunfeng Li; Houjian Cai; Ashkan Morim; Shunyou Wang; Seema Plaisier; Isla P Garraway; Jiaoti Huang; Thomas G Graeber; Hong Wu
Journal:  Cancer Cell       Date:  2011-05-27       Impact factor: 31.743

Review 6.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

7.  Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.

Authors:  Minjung J Kim; Robert D Cardiff; Nishita Desai; Whitney A Banach-Petrosky; Ramon Parsons; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Intronic DNA elements regulate androgen-dependent expression of the murine Nkx3.1 gene.

Authors:  Chinatsu Kojima; Yan Zhang; Warren E Zimmer
Journal:  Gene Expr       Date:  2010

9.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

10.  A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis.

Authors:  Karel De Gendt; Johannes V Swinnen; Philippa T K Saunders; Luc Schoonjans; Mieke Dewerchin; Ann Devos; Karen Tan; Nina Atanassova; Frank Claessens; Charlotte Lécureuil; Walter Heyns; Peter Carmeliet; Florian Guillou; Richard M Sharpe; Guido Verhoeven
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

View more
  9 in total

Review 1.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

2.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

Review 3.  From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

Authors:  Chuan Yu; Kevin Hu; Daniel Nguyen; Zhu A Wang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

4.  Sox2 Expression Marks Castration-Resistant Progenitor Cells in the Adult Murine Prostate.

Authors:  Erin McAuley; Daniel Moline; Calvin VanOpstall; Sophia Lamperis; Ryan Brown; Donald J Vander Griend
Journal:  Stem Cells       Date:  2019-02-15       Impact factor: 6.277

5.  Sexual fate of murine external genitalia development: Conserved transcriptional competency for male-biased genes in both sexes.

Authors:  Daiki Kajioka; Kentaro Suzuki; Shoko Matsushita; Shinjiro Hino; Tetsuya Sato; Shuji Takada; Kyoichi Isono; Toru Takeo; Mizuki Kajimoto; Naomi Nakagata; Mitsuyoshi Nakao; Mikita Suyama; Tony DeFalco; Shinichi Miyagawa; Gen Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

6.  HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma.

Authors:  Andrei Daniel Timofte; Simona Eliza Giuşcă; Ludmila Lozneanu; Mariana Bianca Manole; Iulian Prutianu; Bogdan Gafton; Andreea Rusu; Irina Draga Căruntu
Journal:  Rom J Morphol Embryol       Date:  2021 Jan-Mar       Impact factor: 1.033

7.  Loading of "cocktail siRNAs" into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer.

Authors:  Yanjun Diao; Gangqiang Wang; Bingbing Zhu; Zhuo Li; Shan Wang; Lijuan Yu; Rui Li; Weixiao Fan; Yue Zhang; Lei Zhou; Liu Yang; Xiaoke Hao; Jiayun Liu
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.742

8.  Luminal-contact-inhibition of epithelial basal stem cell multipotency in prostate organogenesis and homeostasis.

Authors:  Corrigan Horton; Yueli Liu; Chuan Yu; Qing Xie; Zhu A Wang
Journal:  Biol Open       Date:  2019-10-01       Impact factor: 2.422

Review 9.  Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.

Authors:  Chia-Lin Chen; Ching-Yu Lin; Hsing-Jien Kung
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.